These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7326694)

  • 21. In vitro and in vivo antibacterial activities of a new injectable carbapenem, S-4661, against gynaecological pathogens.
    Mikamo H; Izumi K; Hua YX; Hayasaki Y; Sato Y; Tamaya T
    J Antimicrob Chemother; 2000 Sep; 46(3):471-4. PubMed ID: 10980177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A decisive period in cefoxitin prophylaxis of experimental synergistic wound infection produced by Bacteroides fragilis and Escherichia coli.
    Shapiro M; Sacks T
    Isr J Med Sci; 1982 Aug; 18(8):863-5. PubMed ID: 6749759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determining the degree of microbial contamination of wounds and microbial sensitivity to antibacterial drugs by the TTX test].
    Buianov VM; Rodoman GV; Zav'ialov BG
    Sov Med; 1985; (2):75-7. PubMed ID: 3992331
    [No Abstract]   [Full Text] [Related]  

  • 24. [Is a repeat treatment of antibiotic therapy necessary?].
    Seeger K
    Tierarztl Prax; 1988; 16(2):109-12. PubMed ID: 3047908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic 6640. 3. Biological studies with antibiotic 6640, a new broad-spectrum aminoglycoside antibiotic.
    Waitz JA; Moss EL; Oden EM; Weinstein MJ
    J Antibiot (Tokyo); 1970 Nov; 23(11):559-65. PubMed ID: 4992170
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of the plaque assay for testing the antibiotic susceptibility of intracellular bacteria.
    Edouard S; Raoult D
    Future Microbiol; 2013 Oct; 8(10):1301-16. PubMed ID: 24059920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary microbiological and pharmacological evaluation of a semisynthetic kasugamycin, BL-A 2.
    Misiek M; Chisholm DR; Leitner F; Price KE
    Antimicrob Agents Chemother (Bethesda); 1969; 9():225-32. PubMed ID: 5396491
    [No Abstract]   [Full Text] [Related]  

  • 28. [Doxycycline. 1. Antibacterial and hematic activity and tissue levels].
    Ciceri R; Clini V; Jeramò A; Mascitelli-Coriandoli E
    Boll Chim Farm; 1970 Oct; 109(10):605-24. PubMed ID: 5515716
    [No Abstract]   [Full Text] [Related]  

  • 29. A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset.
    Chin W; Zhong G; Pu Q; Yang C; Lou W; De Sessions PF; Periaswamy B; Lee A; Liang ZC; Ding X; Gao S; Chu CW; Bianco S; Bao C; Tong YW; Fan W; Wu M; Hedrick JL; Yang YY
    Nat Commun; 2018 Mar; 9(1):917. PubMed ID: 29500445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Microflora and its antibiotic sensitivity in acute inflammatory processes in children].
    Khristich AD; Al'tman ES
    Klin Khir (1962); 1981 Jun; (6):53-5. PubMed ID: 7277968
    [No Abstract]   [Full Text] [Related]  

  • 31. S-nitrosated α-1-acid glycoprotein kills drug-resistant bacteria and aids survival in sepsis.
    Watanabe K; Ishima Y; Akaike T; Sawa T; Kuroda T; Ogawa W; Watanabe H; Suenaga A; Kai T; Otagiri M; Maruyama T
    FASEB J; 2013 Jan; 27(1):391-8. PubMed ID: 23047897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of antibacterial activities of antibiotics in vitro and in animal models of infection.
    Zak O; Tosch W; Sande MA
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():273-82. PubMed ID: 3980330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiological and pharmacological evaluation of BL-C 43, a new semisynthetic derivative of coumermycin A1.
    Price KE; Chisholm DR; Leitner F; Misiek M
    Antimicrob Agents Chemother (Bethesda); 1969; 9():209-18. PubMed ID: 5396489
    [No Abstract]   [Full Text] [Related]  

  • 34. Human infection from an unidentified erythrocyte-associated bacterium.
    Archer GL; Coleman PH; Cole RM; Duma RJ; Johnston CL
    N Engl J Med; 1979 Oct; 301(17):897-900. PubMed ID: 113680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental chemotherapeutic activity of sisomycin sulfate].
    Lobuseva AN; Fomina IP; Pozdniakova VP; Berezina EK; Ivanitskaia LP
    Antibiotiki; 1982 Nov; 27(11):835-9. PubMed ID: 7181467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteria-Targeting Conjugates Based on Antimicrobial Peptide for Bacteria Diagnosis and Therapy.
    Chen H; Liu C; Chen D; Madrid K; Peng S; Dong X; Zhang M; Gu Y
    Mol Pharm; 2015 Jul; 12(7):2505-16. PubMed ID: 26030231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial activity of heneicomycin.
    Frost BM; Valiant ME; Dulaney EL
    J Antibiot (Tokyo); 1979 Jun; 32(6):626-9. PubMed ID: 468738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antibacterial effects of low concentrations of antibiotics and host defence factors: a review.
    Ahlstedt S
    J Antimicrob Chemother; 1981 Nov; 8 Suppl C():59-70. PubMed ID: 7319989
    [No Abstract]   [Full Text] [Related]  

  • 39. [Activity "in vitro" of antibiotics after irradiation with gamma rays of cobalt-60].
    Curatola G; Di Addario A; Garroni C
    Minerva Med; 1969 Oct; 60(81):3903-11. PubMed ID: 5348219
    [No Abstract]   [Full Text] [Related]  

  • 40. Persistent and susceptible bacteria with individual deaths.
    Zucca F
    J Theor Biol; 2014 Feb; 343():69-78. PubMed ID: 24270094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.